PIONEERING biotechnology firm, ReViral is enjoying its new North East research facility at NETPark where it is developing a highly potent drug to target a common virus.

The London-based company has almost reached the clinical trials stage of its drug, which will combat Respiratory Syncytial Virus (RSV) – a virus which infects the lungs and can cause bronchiolitis and pneumonia and is particularly dangerous in those with compromised immune systems, particularly when found in young children and the elderly.

Durham University lecturer Dr Stuart Cockerill and his former colleagues at Arrow Therapeutics combined their expertise in the areas of virology and antiviral therapies when they set up ReViral in 2011.

The company was boosted when it won a prestigious £3.4m Seeding Drug Discovery Award from the Wellcome Trust to fund its first RSV antiviral programme to the stage of filing for their first clinical trial.

Now ReViral has opened a research facility at the North East Technology Park, (NETPark) in Sedgefield, County Durham where it will be creating five jobs. It joins scores of other high tech medical companies which are making huge advancements in the healthcare industry.

Said Dr Cockerill, who is also a senior lecturer in medicinal chemistry at Durham University: “It’s been hard work to get to this point but it’s very exciting to be here now. Treatment for RSV represents a very important multi-billion dollar market since up until very recently there’s been no effective treatment for it.”




NETPark Incubator, Thomas Wright Way, NETPark, Sedgefield, County Durham, TS21 3FD



01740 625250


This email address is being protected from spambots. You need JavaScript enabled to view it.


  • janet_todd_netpark

    Janet Todd

    NETPark Manager

    +44(0)1740 625 250
    This email address is being protected from spambots. You need JavaScript enabled to view it.

Did You Know?

  • Catapulting technologies to market +

    NETPark is the only science park in the UK with two Catapults: High Value Manufacturing and Satellite Applications
  • Reinnervate in space... +

    Reinnervate’s cell scaffold technology was carried to the International Space Station in April 2015 for bone density experiments
  • The Number 55 +

    NETPark is number 55 on the list of 100 reasons why it’s great up north
  • Kromek, a home-grown plc +

    Kromek, a company at NETPark, started with 2 employees, now employs 60, is a plc and is building the largest radiation sensor network in the United States
  • PolyPhotonix and the Sleep Mask +

    PolyPhotonix has developed a Sleep Mask to treat diabetic retinopathy which will save the NHS £1BN a year
  • The North East workforce +

    Companies developing products from physics-based science employ over 43,000 people in the North East
  • Starring in Stargazing Live +

    Durham University's Centre for Advanced Instrumentation at NETPark built instruments for the South African Large Telescope and the James Webb Space Telescope, both of which "starred" in BBC's Stargazing Live
  • 1

Keep In Touch

NETPark associations